glp-1 weight loss news

Weight loss drug is not taking easy way out

Oprah Winfrey reveals taking GLP-1 weight-loss drug made her realize what she got wrong about ‘thin people’

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That changed after a special on weight loss with experts and clinicians that she taped in July 2023. The panel discussion left her with her “biggest aha moment” about the medication.

E! · 16h

Oprah Winfrey Shares What She Learned About “Thin People” After Experience With Weight-Loss Drug

Oprah Winfrey recently detailed how taking weight loss drugs shifted her longtime mindset about what she described as “thin people.”

IFLScience · 4d

Not Just For Weight Loss: GLP-1 Drugs May Affect Addiction And Dementia Risk

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

15hon MSN

Novo Nordisk stock surges 7% after Ozempic maker’s latest weight loss drug shows promise

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

4don MSN

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

21hon MSN

Novo Nordisk reports 22% weight loss in early subcutaneous amycretin trial

Novo Nordisk on Friday announced early-stage trial results for its amycretin obesity drug for subcutaneous injection, saying ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Demand for loose skin surgery rises with GLP-1 weight loss meds

As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity, doctors are observing a surge in patients ...

The Washington Post5d

Sweeping review suggests weight-loss drugs’ effect on 175 conditions

A study by the Department of Veterans Affairs on the relationship between GLP-1 weight-loss drugs and 175 diseases and conditions supports a lot of what scientists already suspected about ...

18h

Novo Nordisk next-gen shot shows 22% weight loss in early results

Novo Nordisk on Friday announced early-stage trial results for its amycretin obesity drug for subcutaneous injection, saying ...

U.S. News & World Report3d

Popular GLP-1 Drugs Are Shaping Health Beyond Weight Loss & Diabetes By India Edwards HealthDay Reporter TUESDAY, Jan. 21, 2025 (HealthDay News) -- Popular GLP-1 medications for weight ...

TAG24 NEWS on MSN22h

Major study of weight-loss jabs shows slew of benefits but also risks

Hugely popular weight-loss jabs like Wegovy have been making headlines for enabling people to manage diabetes and excess weight along with other benefits, scientists say.Increasingly recommended by ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results